Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1
Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these condit...
Gespeichert in:
Veröffentlicht in: | The American heart journal 2010-12, Vol.160 (6), p.1137-1141.e1 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1141.e1 |
---|---|
container_issue | 6 |
container_start_page | 1137 |
container_title | The American heart journal |
container_volume | 160 |
creator | Bhakta, Deepak, MD Groh, Miriam R., MS Shen, Changyu, PhD Pascuzzi, Robert M., MD Groh, William J., MD, MPH |
description | Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these conditions and associated findings in a large population with DM1. Methods History, physical examination, genetic testing, and electrocardiography were performed on 406 patients with DM1, and cardiac imaging was performed on 180 (44.3%) of these patients. Results Left ventricular systolic dysfunction and clinical HF were found in 34 (18.9%) of 180 and in 23 (5.7%) of 406 of enrolled subjects, respectively, yielding an overall prevalence of LVSD/HF in 41 (10.1%) of 406. Increasing age, male sex, electrocardiographic conduction abnormalities, presence of atrial and ventricular arrhythmias, and implanted devices were all significantly associated with LVSD/HF, whereas cytosine-thiamine-guanine repeat length and neuromuscular severity score were not. The interval ≥240 milliseconds (relative risk 4.1, 95% CI 1.7-9.6, P = .001) and QRS duration ≥120 milliseconds (relative risk 4.2, 95% CI 2.0-8.5, P < .001) were significant predictors of LVSD/HF. The presence of LVSD/HF was also significantly associated with all-cause death (relative risk 3.9, 95% CI 2.3-6.4, P < .001) and cardiac death (relative risk 5.7, 95% CI 2.6-12.4, P < .001). Conclusions A significant prevalence of LVSD/HF exists in patients with DM1. The presence of LVSD/HF in DM1 is significantly associated with all-cause and cardiac death. |
doi_str_mv | 10.1016/j.ahj.2010.07.032 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_820957674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002870310006794</els_id><sourcerecordid>820957674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-b12e9940729b353d86d96067d74c67f7b61b7f51e8c02af77c2a63e2a70c82043</originalsourceid><addsrcrecordid>eNp9kl-L1TAQxYso7nX1A_giARGfep2kadIiLMjin4UFH9TnkKZTbmpuc03SlX57U3p1YR98ChN-Z5iZc4riJYU9BSrejXt9GPcMcg1yDxV7VOwotLIUkvPHxQ4AWNlIqC6KZzGOuRSsEU-LC0YpF0K0u2K5mUxAHbEnRx-SdjYt5LdNB-JwSOQOpxSsmZ0OJC4xeWcN6Zc4zJNJ1k9ETz05oA6JDNq6OSCx-bOfXYpbm-Pik582VQr-dFhIWk5I6PPiyaBdxBfn97L48enj9-sv5e3XzzfXH25Lw0Wdyo4ybFsOkrVdVVd9I_pWgJC95EbIQXaCdnKoKTYGmB6kNEyLCpmWYBoGvLos3m59T8H_mjEmdbTRoHN6Qj9HlaG2lvlimXz9gBz9HKY8nKI1cMEBGpopulEm-BgDDuoU7FGHRVFQqy1qVNkWtdqiQKpsS9a8OneeuyP2_xR_fcjAmzOgo9FuCHoyNt5zleR5yiZz7zcO88XuLAYVjcXJYG8DmqR6b_87xtUDtXE2e6PdT1ww3m-rIlOgvq35WeND1-TIlld_APNnv_E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504640081</pqid></control><display><type>article</type><title>Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Bhakta, Deepak, MD ; Groh, Miriam R., MS ; Shen, Changyu, PhD ; Pascuzzi, Robert M., MD ; Groh, William J., MD, MPH</creator><creatorcontrib>Bhakta, Deepak, MD ; Groh, Miriam R., MS ; Shen, Changyu, PhD ; Pascuzzi, Robert M., MD ; Groh, William J., MD, MPH</creatorcontrib><description>Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these conditions and associated findings in a large population with DM1. Methods History, physical examination, genetic testing, and electrocardiography were performed on 406 patients with DM1, and cardiac imaging was performed on 180 (44.3%) of these patients. Results Left ventricular systolic dysfunction and clinical HF were found in 34 (18.9%) of 180 and in 23 (5.7%) of 406 of enrolled subjects, respectively, yielding an overall prevalence of LVSD/HF in 41 (10.1%) of 406. Increasing age, male sex, electrocardiographic conduction abnormalities, presence of atrial and ventricular arrhythmias, and implanted devices were all significantly associated with LVSD/HF, whereas cytosine-thiamine-guanine repeat length and neuromuscular severity score were not. The interval ≥240 milliseconds (relative risk 4.1, 95% CI 1.7-9.6, P = .001) and QRS duration ≥120 milliseconds (relative risk 4.2, 95% CI 2.0-8.5, P < .001) were significant predictors of LVSD/HF. The presence of LVSD/HF was also significantly associated with all-cause death (relative risk 3.9, 95% CI 2.3-6.4, P < .001) and cardiac death (relative risk 5.7, 95% CI 2.6-12.4, P < .001). Conclusions A significant prevalence of LVSD/HF exists in patients with DM1. The presence of LVSD/HF in DM1 is significantly associated with all-cause and cardiac death.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2010.07.032</identifier><identifier>PMID: 21146669</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Biological and medical sciences ; Cardiac arrhythmia ; Cardiology. Vascular system ; Cardiovascular ; Disease Progression ; Diseases of striated muscles. Neuromuscular diseases ; Drug therapy ; Electrocardiography ; Female ; Follow-Up Studies ; Heart ; Heart attacks ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Heart Failure, Systolic - diagnosis ; Heart Failure, Systolic - etiology ; Heart Failure, Systolic - mortality ; Humans ; Kinases ; Male ; Medical sciences ; Muscular dystrophy ; Myotonic Dystrophy - complications ; Myotonic Dystrophy - mortality ; Neurology ; Prognosis ; Prospective Studies ; Risk Factors ; Severity of Illness Index ; Survival Rate - trends ; United States - epidemiology ; Ventricular Dysfunction, Left - diagnosis ; Ventricular Dysfunction, Left - etiology ; Ventricular Dysfunction, Left - mortality</subject><ispartof>The American heart journal, 2010-12, Vol.160 (6), p.1137-1141.e1</ispartof><rights>Mosby, Inc.</rights><rights>2010 Mosby, Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Mosby, Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-b12e9940729b353d86d96067d74c67f7b61b7f51e8c02af77c2a63e2a70c82043</citedby><cites>FETCH-LOGICAL-c465t-b12e9940729b353d86d96067d74c67f7b61b7f51e8c02af77c2a63e2a70c82043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1504640081?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23740958$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21146669$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhakta, Deepak, MD</creatorcontrib><creatorcontrib>Groh, Miriam R., MS</creatorcontrib><creatorcontrib>Shen, Changyu, PhD</creatorcontrib><creatorcontrib>Pascuzzi, Robert M., MD</creatorcontrib><creatorcontrib>Groh, William J., MD, MPH</creatorcontrib><title>Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these conditions and associated findings in a large population with DM1. Methods History, physical examination, genetic testing, and electrocardiography were performed on 406 patients with DM1, and cardiac imaging was performed on 180 (44.3%) of these patients. Results Left ventricular systolic dysfunction and clinical HF were found in 34 (18.9%) of 180 and in 23 (5.7%) of 406 of enrolled subjects, respectively, yielding an overall prevalence of LVSD/HF in 41 (10.1%) of 406. Increasing age, male sex, electrocardiographic conduction abnormalities, presence of atrial and ventricular arrhythmias, and implanted devices were all significantly associated with LVSD/HF, whereas cytosine-thiamine-guanine repeat length and neuromuscular severity score were not. The interval ≥240 milliseconds (relative risk 4.1, 95% CI 1.7-9.6, P = .001) and QRS duration ≥120 milliseconds (relative risk 4.2, 95% CI 2.0-8.5, P < .001) were significant predictors of LVSD/HF. The presence of LVSD/HF was also significantly associated with all-cause death (relative risk 3.9, 95% CI 2.3-6.4, P < .001) and cardiac death (relative risk 5.7, 95% CI 2.6-12.4, P < .001). Conclusions A significant prevalence of LVSD/HF exists in patients with DM1. The presence of LVSD/HF in DM1 is significantly associated with all-cause and cardiac death.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Disease Progression</subject><subject>Diseases of striated muscles. Neuromuscular diseases</subject><subject>Drug therapy</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Heart Failure, Systolic - diagnosis</subject><subject>Heart Failure, Systolic - etiology</subject><subject>Heart Failure, Systolic - mortality</subject><subject>Humans</subject><subject>Kinases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscular dystrophy</subject><subject>Myotonic Dystrophy - complications</subject><subject>Myotonic Dystrophy - mortality</subject><subject>Neurology</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Survival Rate - trends</subject><subject>United States - epidemiology</subject><subject>Ventricular Dysfunction, Left - diagnosis</subject><subject>Ventricular Dysfunction, Left - etiology</subject><subject>Ventricular Dysfunction, Left - mortality</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kl-L1TAQxYso7nX1A_giARGfep2kadIiLMjin4UFH9TnkKZTbmpuc03SlX57U3p1YR98ChN-Z5iZc4riJYU9BSrejXt9GPcMcg1yDxV7VOwotLIUkvPHxQ4AWNlIqC6KZzGOuRSsEU-LC0YpF0K0u2K5mUxAHbEnRx-SdjYt5LdNB-JwSOQOpxSsmZ0OJC4xeWcN6Zc4zJNJ1k9ETz05oA6JDNq6OSCx-bOfXYpbm-Pik582VQr-dFhIWk5I6PPiyaBdxBfn97L48enj9-sv5e3XzzfXH25Lw0Wdyo4ybFsOkrVdVVd9I_pWgJC95EbIQXaCdnKoKTYGmB6kNEyLCpmWYBoGvLos3m59T8H_mjEmdbTRoHN6Qj9HlaG2lvlimXz9gBz9HKY8nKI1cMEBGpopulEm-BgDDuoU7FGHRVFQqy1qVNkWtdqiQKpsS9a8OneeuyP2_xR_fcjAmzOgo9FuCHoyNt5zleR5yiZz7zcO88XuLAYVjcXJYG8DmqR6b_87xtUDtXE2e6PdT1ww3m-rIlOgvq35WeND1-TIlld_APNnv_E</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Bhakta, Deepak, MD</creator><creator>Groh, Miriam R., MS</creator><creator>Shen, Changyu, PhD</creator><creator>Pascuzzi, Robert M., MD</creator><creator>Groh, William J., MD, MPH</creator><general>Mosby, Inc</general><general>Mosby</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1</title><author>Bhakta, Deepak, MD ; Groh, Miriam R., MS ; Shen, Changyu, PhD ; Pascuzzi, Robert M., MD ; Groh, William J., MD, MPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-b12e9940729b353d86d96067d74c67f7b61b7f51e8c02af77c2a63e2a70c82043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Disease Progression</topic><topic>Diseases of striated muscles. Neuromuscular diseases</topic><topic>Drug therapy</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Heart Failure, Systolic - diagnosis</topic><topic>Heart Failure, Systolic - etiology</topic><topic>Heart Failure, Systolic - mortality</topic><topic>Humans</topic><topic>Kinases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscular dystrophy</topic><topic>Myotonic Dystrophy - complications</topic><topic>Myotonic Dystrophy - mortality</topic><topic>Neurology</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Survival Rate - trends</topic><topic>United States - epidemiology</topic><topic>Ventricular Dysfunction, Left - diagnosis</topic><topic>Ventricular Dysfunction, Left - etiology</topic><topic>Ventricular Dysfunction, Left - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhakta, Deepak, MD</creatorcontrib><creatorcontrib>Groh, Miriam R., MS</creatorcontrib><creatorcontrib>Shen, Changyu, PhD</creatorcontrib><creatorcontrib>Pascuzzi, Robert M., MD</creatorcontrib><creatorcontrib>Groh, William J., MD, MPH</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhakta, Deepak, MD</au><au>Groh, Miriam R., MS</au><au>Shen, Changyu, PhD</au><au>Pascuzzi, Robert M., MD</au><au>Groh, William J., MD, MPH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>160</volume><issue>6</issue><spage>1137</spage><epage>1141.e1</epage><pages>1137-1141.e1</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these conditions and associated findings in a large population with DM1. Methods History, physical examination, genetic testing, and electrocardiography were performed on 406 patients with DM1, and cardiac imaging was performed on 180 (44.3%) of these patients. Results Left ventricular systolic dysfunction and clinical HF were found in 34 (18.9%) of 180 and in 23 (5.7%) of 406 of enrolled subjects, respectively, yielding an overall prevalence of LVSD/HF in 41 (10.1%) of 406. Increasing age, male sex, electrocardiographic conduction abnormalities, presence of atrial and ventricular arrhythmias, and implanted devices were all significantly associated with LVSD/HF, whereas cytosine-thiamine-guanine repeat length and neuromuscular severity score were not. The interval ≥240 milliseconds (relative risk 4.1, 95% CI 1.7-9.6, P = .001) and QRS duration ≥120 milliseconds (relative risk 4.2, 95% CI 2.0-8.5, P < .001) were significant predictors of LVSD/HF. The presence of LVSD/HF was also significantly associated with all-cause death (relative risk 3.9, 95% CI 2.3-6.4, P < .001) and cardiac death (relative risk 5.7, 95% CI 2.6-12.4, P < .001). Conclusions A significant prevalence of LVSD/HF exists in patients with DM1. The presence of LVSD/HF in DM1 is significantly associated with all-cause and cardiac death.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>21146669</pmid><doi>10.1016/j.ahj.2010.07.032</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-8703 |
ispartof | The American heart journal, 2010-12, Vol.160 (6), p.1137-1141.e1 |
issn | 0002-8703 1097-6744 |
language | eng |
recordid | cdi_proquest_miscellaneous_820957674 |
source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
subjects | Adult Biological and medical sciences Cardiac arrhythmia Cardiology. Vascular system Cardiovascular Disease Progression Diseases of striated muscles. Neuromuscular diseases Drug therapy Electrocardiography Female Follow-Up Studies Heart Heart attacks Heart failure, cardiogenic pulmonary edema, cardiac enlargement Heart Failure, Systolic - diagnosis Heart Failure, Systolic - etiology Heart Failure, Systolic - mortality Humans Kinases Male Medical sciences Muscular dystrophy Myotonic Dystrophy - complications Myotonic Dystrophy - mortality Neurology Prognosis Prospective Studies Risk Factors Severity of Illness Index Survival Rate - trends United States - epidemiology Ventricular Dysfunction, Left - diagnosis Ventricular Dysfunction, Left - etiology Ventricular Dysfunction, Left - mortality |
title | Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T17%3A54%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20mortality%20with%20left%20ventricular%20systolic%20dysfunction%20and%20heart%20failure%20in%20adults%20with%20myotonic%20dystrophy%20type%201&rft.jtitle=The%20American%20heart%20journal&rft.au=Bhakta,%20Deepak,%20MD&rft.date=2010-12-01&rft.volume=160&rft.issue=6&rft.spage=1137&rft.epage=1141.e1&rft.pages=1137-1141.e1&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/j.ahj.2010.07.032&rft_dat=%3Cproquest_cross%3E820957674%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504640081&rft_id=info:pmid/21146669&rft_els_id=1_s2_0_S0002870310006794&rfr_iscdi=true |